MedTrace Logo

Clinical Trial To Study The Anti-scarring Effect Of Cicatricell

NCT03020420 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-06-05

No results posted yet for this study

Summary

This study tries to prove that Cicatricell cream significantly reduces scarring with better wound appearance as compared to no treatment.

Conditions

  • Surgical Incisions

Interventions

OTHER

Cicatricell Cream

Cream to be applied 2 times a day for 8weeks to 6 months

Sponsors & Collaborators

  • University of Toledo Health Science Campus

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2018-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03020420 on ClinicalTrials.gov